Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
Clinical trial NCT06646497 · RECRUITING
Trial details
- NCT number
- NCT06646497
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-24
- Primary completion
- 2030-01-24
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.